Get started
Pharma-Bio Serv, Inc.Pharma-Bio Serv, Inc.Pharma-Bio Serv, Inc.

Pharma-Bio Serv, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

PBSV chart


Full chart

PBSV upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪12.99 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.0366 USD
Net income (FY)
‪1.31 M‬ USD
Revenue (FY)
‪16.98 M‬ USD
Shares float
‪8.09 M‬
Beta (1Y)
−0.23

Employees


Employees (FY)
100
Change (1Y)
−40 −28.57%
Revenue / Employee (1Y)
‪169.77 K‬ USD
Net income / Employee (1Y)
‪13.10 K‬ USD

About Pharma-Bio Serv, Inc.


Sector
Commercial Services
Industry
Miscellaneous Commercial Services
CEO
Victor Sanchez
Website
pharmabioserv.com
Headquarters
Dorado
Founded
1993
FIGI
BBG000QDNMT7
Pharma-Bio Serv, Inc. engages in the provision of technical compliance consulting service and microbiological and chemical laboratory testing services to the pharmaceutical, chemical, medical device, and biotechnology industries. It operates through the following business segments: Puerto Rico Consulting; United States Consulting; Europe Consulting; and Other. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

PBSV news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of PBSV is 0.5900 USD — it has increased by 1.72% in the past 24 hours. Watch Pharma-Bio Serv, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Pharma-Bio Serv, Inc. stocks are traded under the ticker PBSV.
PBSV stock has risen by 6.35% compared to the previous week, the month change is a −9.23% fall, over the last year Pharma-Bio Serv, Inc. has showed a −40.34% decrease.
We've gathered analysts' opinions on Pharma-Bio Serv, Inc. future price: according to them, PBSV price has a max estimate of 1.65 USD and a min estimate of 1.65 USD. Watch PBSV chart and read a more detailed Pharma-Bio Serv, Inc. stock forecast: see what analysts think of Pharma-Bio Serv, Inc. and suggest that you do with its stocks.
PBSV reached its all-time high on Nov 15, 2013 with the price of 2.5000 USD, and its all-time low was 0.1000 USD and was reached on Apr 1, 2010. View more price dynamics on PBSV chart.
See other stocks reaching their highest and lowest prices.
PBSV stock is 1.69% volatile and has beta coefficient of −0.23. Track Pharma-Bio Serv, Inc. stock price on the chart and check out the list of the most volatile stocks — is Pharma-Bio Serv, Inc. there?
Today Pharma-Bio Serv, Inc. has the market capitalization of ‪12.88 M‬, it has decreased by −2.14% over the last week.
Yes, you can track Pharma-Bio Serv, Inc. financials in yearly and quarterly reports right on TradingView.
Pharma-Bio Serv, Inc. is going to release the next earnings report on Jan 1, 2025. Keep track of upcoming events with our Earnings Calendar.
PBSV earnings for the last quarter are −0.01 USD per share, whereas the estimation was 0.03 USD resulting in a −133.33% surprise. The estimated earnings for the next quarter are 0.03 USD per share. See more details about Pharma-Bio Serv, Inc. earnings.
Pharma-Bio Serv, Inc. revenue for the last quarter amounts to ‪2.40 M‬ USD, despite the estimated figure of ‪3.50 M‬ USD. In the next quarter, revenue is expected to reach ‪4.00 M‬ USD.
PBSV net income for the last quarter is ‪−309.19 K‬ USD, while the quarter before that showed ‪−213.82 K‬ USD of net income which accounts for −44.61% change. Track more Pharma-Bio Serv, Inc. financial stats to get the full picture.
Pharma-Bio Serv, Inc. dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 8, 2024, the company has 100.00 employees. See our rating of the largest employees — is Pharma-Bio Serv, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Pharma-Bio Serv, Inc. EBITDA is ‪−896.94 K‬ USD, and current EBITDA margin is 7.73%. See more stats in Pharma-Bio Serv, Inc. financial statements.
Like other stocks, PBSV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Pharma-Bio Serv, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Pharma-Bio Serv, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Pharma-Bio Serv, Inc. stock shows the sell signal. See more of Pharma-Bio Serv, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.